Study finds 18 percent chance Ebola will arrive in the U.S. this month


The outbreak of Ebola in West Africa has public health officials very alarmed. It is the world's largest and deadliest outbreak yet, and has infected about 3,600 people and killed at least 1,841 in three countries, according to the World Health Organization's tally. But there's a good chance the virus will spread outside of Guinea, Sierra Leone, and Liberia.
How good a chance? A study this week puts the odds that Ebola will arrive in the U.S. in late September as high as 18 percent. The study, published in PLOS Currents: Outbreaks, analyzed patterns of daily flights from the infected countries, keeping in mind how hard it will be to keep an infected person from boarding commercial airliners:
The 18 percent figure is the high end of the study's range for the U.S., but "what is happening in West Africa is going to get here," senior author Alessandro Vespignani tells NPR. "We can't escape that at this point." Vespignani isn't predicting a massive outbreak like in Africa, but "very small clusters of cases, between one and three." The odds of an Ebola panic are probably higher.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Still, the U.S. is fortunate in comparison. The chances of an Ebola carrier arriving elsewhere in Africa is much higher, and Britain's odds are as high as 25-28 percent by late September, the study found.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Democrats: The 2028 race has begun
Feature Democratic primaries have already kicked off in South Carolina
-
The Pentagon's missing missiles
Feature The U.S. military is low on weapons. Can it restock before a major conflict breaks out?
-
Rescissions: Trump's push to control federal spending
Feature The GOP passed a bill to reduce funding for PBS, NPR and other public media stations
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths